In particular, TIMP-1 (the tissue inhibitor of MMP-9) is significantly lower in plasma of AD patients than in controls23, while it increases in the CSF of patients with AD and Mild Cognitive Impairment (MCI)8,24. This evidence concerns the gene MMP9 and Alzheimer disease.